Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Michael Pishvaian, MD, PhD
<< Back to Our Featured Experts
Dr. Pishvaian Discusses Atezolizumab Plus Bevacizumab in HCC
Dr. Pishvaian on Implications of Entrectinib Study in Pancreatic Cancer
Dr. Pishvaian on the Future of Entrectinib in Pancreatic Cancer
Dr. Pishvaian on Precision Medicine in GI Cancer
Dr. Pishvaian on Molecular Alteration in Pancreatic Cancer
Dr. Pishvaian Discusses Progress in Pancreatic Cancer
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Omar Nadeem, MD
Eric S. Nadler, MD
Sukumar Nagendran, MD
Jarushka Naidoo, MBBCh
Arpana M. Naik, MD
Kazuhiko Nakagawa, MD, PhD
Sujatha Nallapareddy, MD
Azadeh Namakydoust, MD, FACP
Dhanya K. Nambiar, PhD
Dhanya K. Nambiar
Dhanya K. Nambier, PhD
Rita Nanda, MD
Julie R. Nangia, MD
Julie R. Nangia
David Nanus, MD
David M. Nanus, MD
Amol K. Narang, MD
Elham Nasri, MD
Loretta J. Nastoupil, MD
Paul D. Nathan, MBBS, PhD, FRCP
Nitya Nathwani, MD
R. Wendel Naumann, MD
Shoba A. Navai, MD
Aziz Nazha, MD
Joel Neal, MD
Joel Neal, MD, PhD
Joel Neal, MD, PhD
Sattva Neelapu, MD
Sattva S. Neelapu, MD
Douglas A. Nelson, MD
Leigh A. Neumayer, MD
Thomas A. Neville, PhD
Lisa A. Newman, MD
Lisa Newman, MD, MPH, FACS, FASCO
Vincent Y. Ng, MD
Paul Nghiem, MD, PhD
Trung Nguyen, DO, MBA
Marie Huong Nguyen, MD
Torsten O. Nielsen, MD, PhD, FRCPC
Ruben Niesvizky, MD
Yuri E. Nikiforov, MD, PhD
Stephen D. Nimer, MD
Ajay K. Nooka, MD, MPH, FACP
Andrew Norden, MD, MPH, MBA
Luke Nordquist, MD
Luke Nordquist, MD, FACP
Silvia Novello, MD, PhD
Yelena Novik, MD
Grzegorz S. Nowakowski, MD
Brian Nussenbaum, MD
Lauren Nye, MD
OncLive News Network On Location: ASH 2019 Day 3
Trending Now
Neoadjuvant Olaparib Combo Safe in Breast Cancer
Key Takeaway 3: Role of Frontline I/O Still Pending
De-Escalation Possible in Curative Setting for HER2+ Breast Cancer
Key Takeaway 4: Second-Line Regorafenib After TKI in HCC
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe